Congress: Pass the Rare Pediatric Disease Priority Review Voucher Reauthorization
The Rare Pediatric Disease Priority Review Voucher program is one of the most important incentives for biopharmaceutical companies to develop new and life-changing treatments for pediatric neuromuscular diseases. This incentive, while continuing along in limited capacity,...